Dr Nick Meyers is an experienced Program Director and Project Leader, with over 25 years’ experience within the industry, working in large pharma, biotech and the CRO sector, delivering internally-resourced and out-sourced projects involving multi-disciplinary teams spanning different companies and geographies.
On moving into industry in the mid-1990s, Nick spent eight years with SmithKline Beecham leading internal research projects and collaborations with academic groups, working and publishing in a number of diverse fields (e.g., oral microbiology, dermatology, hepatology), followed by 12 years working in two small, virtual biotech companies in the UK (Alizyme Therapeutics Ltd and Phytopharm plc), where he was responsible, respectively, for the development of novel small molecules for the treatment of IBS-C & IBS-A and Parkinson’s disease & ALS, taking those assets from pre-clinical development through late-stage clinical trials.
Nick has also worked for the global CRO, PPD Ltd, providing program management support for biotech and small pharma companies developing small molecule and biologics for the treatment of airway diseases; and with Daiichi Sankyo Development, providing program management expertise and project leadership for two products being developed for the treatment of pain indications, and a product being developed for the treatment of asthma.
The breadth and depth of Nick’s R&D experience is considerable, spanning CMC, non-clinical, clinical and regulatory. Throughout his career Nick has worked in close collaboration with commercial colleagues and has previously been closely involved in licensing activities, establishing relationships with pharma partners and authoring patent applications/maintaining patent portfolios.
Nick is now Chief Development Officer at Boyds, which encompasses program management and supporting client companies strategically and operationally with their development programs. The group also undertakes a range of other kinds of projects, including expert reports, technical and commercial due diligence, operational support for start-up companies, and academic spin-outs.
Nick’s industry career was preceded by an academic career as a senior research fellow in virology within the Department of Pathology at the University of Cambridge and with the AFRC Institutes of Animal Health. Nick received his PhD in bacterial genetics in 1990 from the University of Cranfield.
